Steve Schonfeld’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$155K Buy
+45,812
New +$207K ﹤0.01% 2422
2026
Q2
– Sell
-24,221
Closed -$139K – 2831
2026
Q1
$139K Buy
+24,221
New +$172K ﹤0.01% 1837

Other funds holding LXEO

Steve Schonfeld's LXEO Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 45,812 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #2422 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in LXEO as recently as Q1 2026.

Steve Schonfeld first reported a position in LXEO in Q1 2026 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • Steve Schonfeld held 45,812 shares of Lexeo Therapeutics worth $155K as of Q3 2026.
  • Lexeo Therapeutics was a new Steve Schonfeld position in Q3 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2422 holding.
  • Steve Schonfeld first reported a position in Lexeo Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.